Skip to content
Scintria
ToolsGrant writerFunding
HomeLiteratureClinical trialsEvidence LabProtocol packData analysisLearnProjectsLibraryReferencesApplications
Start free
ScintriaStart free

Learn / Epidemiology / Infectious disease epidemiology

HIV, tuberculosis and malaria: the big three in Africa

14 minute read · 6-question quiz

Download this lesson as a colour Word or PDF study guide with the figures and answers. Included in paid plans; reading and quizzes stay free.Sign in

What you will learn

  • Describe the epidemiology and control principles of HIV, TB and malaria

  • Interpret key indicators for each disease

  • Explain how the three interact and why integrated programmes are needed

These three diseases dominate the infectious burden in sub-Saharan Africa and the work of many health systems, research institutes and CROs. This lesson summarises the key epidemiological ideas. Global figures change each year; use the latest WHO and UNAIDS reports for numbers you quote.

HIV

Transmission

Unprotected sex, mother-to-child (pregnancy, birth, breastfeeding), blood and needles. Per-act risk differs widely; viral load drives infectiousness.

Key concept: U=U

People on effective ART with an undetectable viral load do not transmit HIV sexually. Treatment is prevention.

Prevention package

Condoms, voluntary medical male circumcision, PrEP (oral, injectable), PMTCT, harm reduction, testing and early treatment.

Indicators

Prevalence, incidence per 100 person-years, the 95-95-95 cascade, viral suppression, vertical transmission rate, incidence in adolescent girls and young women.

In high-prevalence settings, HIV incidence is concentrated in adolescent girls and young women and their partners; key populations (sex workers, men who have sex with men, people who inject drugs) carry disproportionate risk everywhere. Population-based surveys (UPHIA, DHS) and cohorts (Rakai) give the best incidence data. Because treatment keeps people alive, prevalence falls slowly even when incidence drops.

Tuberculosis

Transmission

Airborne from people with pulmonary TB. Infection becomes active disease in about 5 to 10% over a lifetime; risk is far higher with HIV, malnutrition, diabetes and smoking.

Control

Find and treat cases quickly, contact investigation, preventive treatment for contacts and people with HIV, infection control, BCG for children.

Diagnosis

Symptom screening, rapid molecular tests (Xpert and similar), culture and drug-susceptibility testing, chest X-ray with computer-aided reading.

Indicators

Incidence per 100,000, notification rate, treatment success rate, proportion of cases tested for HIV, drug-resistant TB (RR/MDR-TB), preventive treatment coverage.

The 'missing millions' are people with TB who are never diagnosed or notified; closing this gap is the major challenge. Drug-resistant TB needs longer, costlier regimens, though shorter all-oral regimens are now available.

Malaria

Transmission

Bite of an infected female Anopheles mosquito. Intensity is measured by the entomological inoculation rate (infective bites per person per year).

Immunity

Partial immunity develops after repeated infection, so severe disease is concentrated in young children and pregnant women in high-transmission areas.

Control

Insecticide-treated nets, indoor residual spraying, prompt diagnosis and artemisinin combination therapy, seasonal malaria chemoprevention, intermittent preventive treatment in pregnancy and the RTS,S and R21 vaccines.

Indicators

Parasite prevalence in children 2 to 10 (PfPR), incidence per 1,000, slide positivity, net use, treatment-seeking, test positivity rate, deaths.

Challenges include insecticide resistance, drug resistance (partial artemisinin resistance has emerged in East Africa), Anopheles stephensi invasion of urban areas, humanitarian crises and funding gaps.

How they interact

Raises TB risk 15 to 20 timesMore severe in pregnancyLeading cause of death in PLHIVHIVTuberculosisMalaria
The diseases amplify one another. HIV is the strongest driver of TB; malaria in pregnancy is worse with HIV.

Why integration matters

A woman with HIV attends antenatal care. An integrated visit can offer HIV testing and ART, TB symptom screening and preventive treatment, malaria testing and intermittent preventive treatment, anaemia screening and syphilis testing. Separate vertical programmes would mean four visits and four losses to follow-up. Integrated services also lower cost for the health system and the family.

What to remember about measurement

Each disease has its own best measure: incidence for HIV (not prevalence), notification and treatment success for TB, parasite prevalence and incidence for malaria. Prevalence alone misleads when treatment changes duration.

Numbers change

Global burden figures are updated each year (WHO Global TB Report, World Malaria Report, UNAIDS Global AIDS Update). Always cite the report, the year and the uncertainty range, never a remembered number.

Summary

  • HIV: incidence, the 95-95-95 cascade and U=U define progress; prevention is combination prevention.

  • TB: finding the missing cases, preventive treatment and fast diagnostics are central.

  • Malaria: nets, spraying, prompt treatment, chemoprevention and vaccines, against the threat of resistance.

  • HIV drives TB and complicates malaria in pregnancy; integrated services are more efficient.

  • Choose the indicator that fits each disease and cite the latest report.

Check your understanding

Question 1
1

U=U means:

Question 2
2

The 'missing millions' in TB are:

Question 3
3

Malaria transmission intensity is described by:

Question 4
4

HIV infection raises the risk of active TB by about:

Question 5
5

Improving ART coverage while incidence stays the same will cause prevalence to:

Question 6
6

Seasonal malaria chemoprevention is aimed at:

Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.

Timing, contacts and investigating transmissionNon-communicable diseases and their risk factors